Bioventix PLC (AIM:BVXP)
London · Delayed Price · Currency is GBP · Price in GBX 1,677.00
-23.00 (-1.35%)
May 6, 2026, 4:11 PM GMT
Bioventix Market Cap
Bioventix has a market cap or net worth of 88.82 million as of May 6, 2026. Its market cap has decreased by -32.00% in one year.
Market Cap
88.82M
Enterprise Value
83.52M
Revenue
12.54M
Ranking
n/a
PE Ratio
12.10
Stock Price
1,677.00
Market Cap Chart
Since April 8, 2010, Bioventix's market cap has increased from 9.85M to 88.82M, an increase of 801.98%. That is a compound annual growth rate of 14.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 88.82M | -10.76% |
| Dec 31, 2025 | 99.53M | -39.94% |
| Dec 31, 2024 | 165.72M | -26.16% |
| Dec 29, 2023 | 224.45M | 7.98% |
| Dec 30, 2022 | 207.85M | 17.35% |
| Dec 31, 2021 | 177.12M | -22.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Scancell Holdings | 156.70M |
| Faron Pharmaceuticals Oy | 82.80M |
| 4basebio | 78.16M |
| Ondine Biomedical | 61.05M |
| hVIVO | 50.15M |
| Hemogenyx Pharmaceuticals | 43.47M |
| Poolbeg Pharma | 30.32M |
| Sareum Holdings | 27.96M |